Clinical trial Recruiting at 1 site Observational Ages 19 to 80

Examining vein wall thickness and inflammation in Behçet disease patients

Official title: Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease

Run by Sohag University · NCT06721234 · Data updated 2026-11-12

This study looks at the thickness of vein walls and signs of inflammation in adults with Behçet disease to see how these factors relate to the disease's activity and symptoms.

Quick facts

Study typeObservational
Ages19 Years to 80 Years
SexAll
Enrollment100 (estimated)
SponsorSohag University
Academic / other
Locations1 site (Sohag)
StatusRecruiting
StartedDecember 2, 2024
Main results expectedApril 30, 2025
Study endsJuly 30, 2025
Registry record updatedDecember 10, 2024
Trial IDNCT06721234 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults over 18 years old who have been diagnosed with Behçet disease according to established criteria.

Probably not a fit

Patients with other rheumatological or vascular diseases, or those with significant comorbidities such as hypertension or diabetes, may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study evaluates the thickness of the femoral vein wall and inflammatory markers in patients diagnosed with Behçet disease. It aims to assess the relationship between these factors and the activity of the disease, as well as associated clinical manifestations. The study includes adult patients who meet the International Criteria for Behçet's Disease and are able to provide informed consent. By analyzing these parameters, the study seeks to enhance understanding of the disease's impact on vascular health.

Why it matters

Potential benefit: If successful, this study could provide insights into the vascular complications of Behçet disease, potentially leading to improved management strategies.

How similar studies have gone: While there may be limited studies specifically focusing on vein wall thickness in Behçet disease, similar research on inflammatory markers has shown promising results in understanding disease mechanisms.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients fulfill the International Criteria for Behcet's Disease (ICBD)
* Age above 18 years old
* Patients cooperative and can answer questions
* Patients who are able and willing to give informed consent

Exclusion Criteria:

* Other rheumatological and vascular diseases
* Patients with abnormal hepatic or renal function tests , hyperlipidemia and impaired coagulation tests
* Patients with hypertension , diabetes mellitus , malignant and active infectious diseases
* Patients who are using aspirin and other platelet active drygs during the previous 6 months
* patients who are not able and willing to give written consent

Where it's running

  • Sohag university
    Sohag, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.